PTC Therapeutics Inc. Stock
PTC Therapeutics Inc. Stock
PTC Therapeutics Inc. took a tumble today and lost -€1.200 (-3.410%).
Our community is currently high on PTC Therapeutics Inc. with 15 Buy predictions and 7 Sell predictions.
As a result the target price of 41 € shows a positive potential of 20.59% compared to the current price of 34.0 € for PTC Therapeutics Inc..
For the coming years our community has positive and negative things to say abot the PTC Therapeutics Inc. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "EBIT Margin" there were negative voices in the community.
Pros and Cons of PTC Therapeutics Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
C******** o* t** e**********
Cons
?
B****
?
S********** s********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of PTC Therapeutics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| PTC Therapeutics Inc. | -3.410% | 13.333% | 45.299% | -12.821% | 34.921% | 8.280% | -1.862% |
| Ironwood Pharmaceuticals | -7.500% | -4.310% | -25.503% | -44.221% | -45.588% | -45.050% | - |
| Novocure Ltd | 4.840% | 5.435% | 89.436% | -71.271% | 49.492% | -85.644% | - |
| Iovance Biotherapeutics Inc. | -2.500% | -2.040% | -15.627% | 22.927% | 18.110% | -36.836% | - |
Comments
PTC Therapeutics, Inc. (NASDAQ: PTCT) had its price target raised by analysts at Citigroup Inc. from $18.00 to $26.00. They now have a "sell" rating on the stock.
Show more
Ratings data for PTCT provided by MarketBeat
PTC Therapeutics, Inc. (NASDAQ: PTCT) had its price target raised by analysts at JPMorgan Chase & Co. from $43.00 to $53.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for PTCT provided by MarketBeat
PTC Therapeutics, Inc. (NASDAQ: PTCT) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $18.00 to $32.00. They now have a "sell" rating on the stock.
Show more
Ratings data for PTCT provided by MarketBeat